Oxbryta May Be SCD Blood Transfusions Option in Pandemic, Case Report Finds
News
Treatment with Oxbryta (voxelotor) may be a feasible alternative to blood transfusions for sickle cell disease (SCD) patients who are experiencing respiratory distress and pneumonia related to COVID-19, a ... Read more